Harnessing the full therapeutic potential of the interferon system requires more than just understanding basic virology—it demands a deep dive into subtype diversity and functional divergence. Yet, many promising cytokine interventions struggle to translate from mechanistic discovery into clinical success due to strict species-specific bottlenecks and a lack of highly predictive, human-relevant in vivo environments.

In this webinar, we explore the strategic shift from conventional interferon therapies to precision translational applications. From decoding the biological significance of IFN subtypes to leveraging the advanced humanized IFNAR (hIFNAR) mouse model for high-fidelity efficacy and safety evaluation, we demonstrate how to overcome critical preclinical hurdles. Join us to learn how these advanced models and targeted insights can streamline your workflow and confidently advance your precision IFN candidates from bench to bedside.